Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115081) titled 'A multicenter randomized clinical controlled study on comparing the efficacy of intravitreal injection of different doses of ganciclovir in the treatment of cytomegalovirus retinitis' on Dec. 22, 2025.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Beijing Chaoyang Hospital, Capital Medical University
Condition:
Cytomegalovirus Retinitis
Intervention:
Low-dose group:Induction period (two weeks):Inject 0.4 mg/0.1 mL of GCV into the vitreous cavity, twice a week.
Maintenance period (four weeks):Inject 0.4 mg/0.1 mL of GCV into the vitreous cavity, once a week.
Recruitment Status: N...